These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9387204

  • 1. Risk factors and prevention of vascular complications in polycythemia vera.
    Barbui T, Finazzi G.
    Semin Thromb Hemost; 1997; 23(5):455-61. PubMed ID: 9387204
    [Abstract] [Full Text] [Related]

  • 2. Treatment of polycythemia vera.
    Barbui T, Finazzi G.
    Haematologica; 1998 Feb; 83(2):143-9. PubMed ID: 9549926
    [Abstract] [Full Text] [Related]

  • 3. European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP): a randomized trial.
    Landolfi R, Marchioli R.
    Semin Thromb Hemost; 1997 Feb; 23(5):473-8. PubMed ID: 9387206
    [Abstract] [Full Text] [Related]

  • 4. A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP).
    Finazzi G, low-dose aspirin in polycythemia (ECLAP).
    Pathol Biol (Paris); 2004 Jun; 52(5):285-8. PubMed ID: 15217715
    [Abstract] [Full Text] [Related]

  • 5. Risk-adapted therapy in essential thrombocythemia and polycythemia vera.
    Finazzi G, Barbui T.
    Blood Rev; 2005 Sep; 19(5):243-52. PubMed ID: 15963833
    [Abstract] [Full Text] [Related]

  • 6. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH.
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [Abstract] [Full Text] [Related]

  • 7. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data.
    Finazzi G.
    Semin Thromb Hemost; 2006 Apr; 32(3):276-82. PubMed ID: 16673282
    [Abstract] [Full Text] [Related]

  • 8. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party.
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [Abstract] [Full Text] [Related]

  • 9. Front-line therapy in polycythemia vera and essential thrombocythemia.
    Barbui T, Finazzi MC, Finazzi G.
    Blood Rev; 2012 Sep; 26(5):205-11. PubMed ID: 22784966
    [Abstract] [Full Text] [Related]

  • 10. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 11. Laboratory investigations and prediction of thrombotic risk in polycythemia vera.
    Boneu B.
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):183-5. PubMed ID: 8036139
    [Abstract] [Full Text] [Related]

  • 12. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
    Barbui T, Finazzi G.
    Semin Thromb Hemost; 2007 Jun; 33(4):321-9. PubMed ID: 17525889
    [Abstract] [Full Text] [Related]

  • 13. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients.
    Bachleitner-Hofmann T, Grumbeck E, Gisslinger H.
    Thromb Res; 2003 Jun; 112(4):229-32. PubMed ID: 14987916
    [Abstract] [Full Text] [Related]

  • 14. Expertise-based management in essential thrombocythemia and polycythemia vera.
    Finazzi G, Barbui T.
    Cancer J; 2007 Jun; 13(6):372-6. PubMed ID: 18032974
    [Abstract] [Full Text] [Related]

  • 15. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
    Marchioli R, Finazzi G, Landolfi R, Kutti J, Gisslinger H, Patrono C, Marilus R, Villegas A, Tognoni G, Barbui T.
    J Clin Oncol; 2005 Apr 01; 23(10):2224-32. PubMed ID: 15710945
    [Abstract] [Full Text] [Related]

  • 16. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
    Gangat N, Wolanskyj AP, Schwager SM, Hanson CA, Tefferi A.
    Cancer; 2009 Dec 15; 115(24):5740-5. PubMed ID: 19806641
    [Abstract] [Full Text] [Related]

  • 17. Erythromelalgia and vascular complications in polycythemia vera.
    Michiels JJ.
    Semin Thromb Hemost; 1997 Dec 15; 23(5):441-54. PubMed ID: 9387203
    [Abstract] [Full Text] [Related]

  • 18. A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs.
    Crisà E, Venturino E, Passera R, Prina M, Schinco P, Borchiellini A, Giai V, Ciocca Vasino MA, Bazzan M, Vaccarino A, Boccadoro M, Ferrero D.
    Ann Hematol; 2010 Jul 15; 89(7):691-9. PubMed ID: 20146064
    [Abstract] [Full Text] [Related]

  • 19. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
    Landolfi R, Di Gennaro L, Novarese L, Patrono C.
    Semin Thromb Hemost; 2006 Apr 15; 32(3):251-9. PubMed ID: 16673279
    [Abstract] [Full Text] [Related]

  • 20. The haematocrit and platelet target in polycythemia vera.
    Di Nisio M, Barbui T, Di Gennaro L, Borrelli G, Finazzi G, Landolfi R, Leone G, Marfisi R, Porreca E, Ruggeri M, Rutjes AW, Tognoni G, Vannucchi AM, Marchioli R, European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP) Investigators.
    Br J Haematol; 2007 Jan 15; 136(2):249-59. PubMed ID: 17156406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.